Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M, EUROCARE Working Group: Childhood cancer survival trends in Europe: a EUROCARE working group study. J Clin Oncol. 2005, 23: 3742-3751. 10.1200/JCO.2005.00.554.
Article
PubMed
Google Scholar
Federman N, Bernthal N, Eilber FC, Tap WD: The multidisciplinary management of osteosarcomas. Curr Treat Options Oncol. 2009, 10: 82-93. 10.1007/s11864-009-0087-3.
Article
PubMed
Google Scholar
Wagner TD, Kobayashi W, Dean S, Goldberg SI, Kirsch DG, Suit HD, Hornicek FJ, Pedlow FX, Raskin KA, Springfield DS, Yoon SS, Gebhardt MC, Mankin HJ, Delaney TF: Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone. Int J Radiat Oncol Biol Phys. 2009, 73: 259-266. 10.1016/j.ijrobp.2008.03.074.
Article
PubMed
Google Scholar
DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD: Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005, 61: 492-498. 10.1016/j.ijrobp.2004.05.051.
Article
PubMed
Google Scholar
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H: Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005, 23: 2004-2011. 10.1200/JCO.2005.06.031.
Article
CAS
PubMed
Google Scholar
Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PCW, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW, Taminia AHM: Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst. 2007, 99: 112-128. 10.1093/jnci/djk015.
Article
CAS
PubMed
Google Scholar
Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006, 66: 9339-9344. 10.1158/0008-5472.CAN-06-3126.
Article
CAS
PubMed
Google Scholar
Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008, 8: 755-768. 10.1038/nrc2499.
Article
CAS
PubMed
Google Scholar
Li F, Tiede B, Massague J, Kang Y: Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2007, 17: 3-14. 10.1038/sj.cr.7310118.
Article
CAS
PubMed
Google Scholar
Dean M, Fojo T, Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer. 2005, 5: 275-284. 10.1038/nrc1590.
Article
CAS
PubMed
Google Scholar
Frosina G: The bright and the dark sides of DNA repair in stem cells. J Biomed Biotechnol. 2010, 2010: 845396-
Article
PubMed
PubMed Central
Google Scholar
Moitra K, Lou H, Dean M: Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clin Pharmacol Ther. 2011, 89: 491-502. 10.1038/clpt.2011.14.
Article
CAS
PubMed
Google Scholar
Gottesman MM, Fojo T, Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002, 2: 48-58. 10.1038/nrc706.
Article
CAS
PubMed
Google Scholar
Moore N, Lyle S: Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol. 2011, 2011: 396076-doi:10.1155/2011/396076
Article
PubMed
Google Scholar
Ishikaw F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M, Miyamoto T, Lyons B, Ohshima K, Uchida N, Taniguchi S, Ohara O, Akashi K, Harada M, Shultz LD: Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007, 25: 1315-1321. 10.1038/nbt1350.
Article
Google Scholar
Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN, Steindler DA: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia. 2005, 7: 967-976. 10.1593/neo.05394.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G, Graziano A, Galderisi U, Cavaliere C, De Rosa A, Papaccio G, Giordano A: Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One. 2008, 3: e3469-10.1371/journal.pone.0003469.
Article
PubMed
PubMed Central
Google Scholar
Diehn M, Cho RW, Clarke MF: Therapeutic implications of the cancer stem cell hypothesis. Semin Radiat Oncol. 2009, 19: 78-86. 10.1016/j.semradonc.2008.11.002.
Article
PubMed
PubMed Central
Google Scholar
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006, 8: 315-317. 10.1080/14653240600855905.
Article
CAS
PubMed
Google Scholar
Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z: Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol. 2011, 11: 71-10.1186/1471-230X-11-71. doi:10.1186/1471-230X-11-71
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, Stubblefield K, Rankin-Gee EK, Wang SE: Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene. 2011, 30: 1470-1480. 10.1038/onc.2010.531.
Article
CAS
PubMed
Google Scholar
Fan X, Liu S, Su F, Pan Q, Lin T: Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol. 2010, doi:10.1016/j.urolonc.2010.03.019
Google Scholar
Zhonga Y, Guanb K, Guoa S, Zhoua C, Wanga D, Maa W, Zhanga Y, Lia C, Zhang S: Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett. 2010, 299: 150-160. 10.1016/j.canlet.2010.08.013.
Article
Google Scholar
Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, de Jong D, van Pel M, Cleton-Jansen AM, Hogendoorn PC: Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol. 2009, 219: 294-305. 10.1002/path.2603.
Article
CAS
PubMed
Google Scholar
Wang L, Park P, Lin CY: Characterization of stem cell attributes in human osteosarcoma cell lines. Cancer Biol Ther. 2009, 8: 543-552.
Article
CAS
PubMed
Google Scholar
Levings PP, McGarry SV, Currie TP, Nickerson DM, McClellan S, Ghivizzani SC, Steindler DA, Gibbs CP: Expression of an exogenous human oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res. 2009, 69: 5648-5655. 10.1158/0008-5472.CAN-08-3580.
Article
CAS
PubMed
PubMed Central
Google Scholar
Suvà ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, Suvà D, Clément V, Provero P, Cironi L, Osterheld MC, Guillou L, Stamenkovic I: Identification of cancer stem cells in Ewing's Sarcoma. Cancer Res. 2009, 69: 1776-1781. 10.1158/0008-5472.CAN-08-2242.
Article
PubMed
Google Scholar
Miele E, Spinelli GP, Tomao F, Zullo A, De Marinis F, Pasciuti G, Rossi L, Zoratto F, Tomao S: Positron Emission Tomography (PET) radiotracers in oncology - utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2008, 27: 52-10.1186/1756-9966-27-52.
Article
PubMed
PubMed Central
Google Scholar
Hillner BE, Siegel BA, Shields AF, Liu D, Gareen IF, Hanna L, Stine SH, Coleman RE: The impact of positron emission tomography (PET) on expected management during cancer treatment. Cancer. 2009, 115: 410-418. 10.1002/cncr.24000.
Article
PubMed
Google Scholar
Hsu PP, Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell. 2008, 134: 703-707. 10.1016/j.cell.2008.08.021.
Article
CAS
PubMed
Google Scholar
Heiden MGV, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009, 324: 1029-1033. 10.1126/science.1160809.
Article
Google Scholar
Stuart JA, Brown MF: Energy, quiescence and the cellular basis of animal life spans. Comp Biochem Physiol A Mol Integr Physiol. 2006, 143: 12-23. 10.1016/j.cbpa.2005.11.002.
Article
PubMed
Google Scholar
Wang JCY, Dick JE: Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005, 15: 494-501. 10.1016/j.tcb.2005.07.004.
Article
CAS
PubMed
Google Scholar
Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R, Wunder JS, Alman BA: Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res. 2007, 67: 8216-8222. 10.1158/0008-5472.CAN-07-0999.
Article
CAS
PubMed
Google Scholar
Murase M, Kano M, Tsukahara T, Takahashi A, Torigoe T, Kawagushi S, Wada T, Uchihashi Y, Kondo T, Yamashita T, Sato N: Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer. 2009, 101: 1425-1432. 10.1038/sj.bjc.6605330.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gomes CM, van Paassen H, Romeo S, Welling MM, Feitsma RI, Abrunhosa AJ, Botelho MF, Hogendoorn PC, Pauwels E, Cleton-Jansen AM: Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies. Nucl Med Biol. 2006, 33: 831-840. 10.1016/j.nucmedbio.2006.07.011.
Article
CAS
PubMed
Google Scholar
Shen F, Chu S, Bence AK, Bailey B, Xue X, Erickson PA, Montrose MH, Beck WT, Erickson LC: Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J Pharmacol Exp Ther. 2008, 324: 95-102.
Article
CAS
PubMed
Google Scholar
Gottesman MM: Mechanisms of Cancer Drug Resistance. Annu Rev Med. 2002, 53: 615-627. 10.1146/annurev.med.53.082901.103929.
Article
CAS
PubMed
Google Scholar
Awad O, Yustein JT, Shah P, Gul N, Katuri V, O'Neill A, Kong Y, Brown ML, Toretsky JA, Loeb DM: High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. PLoS One. 2010, 5: e13943-10.1371/journal.pone.0013943.
Article
PubMed
PubMed Central
Google Scholar
Honoki K, Fujii H, Kubo A, Kido A, Mori T, Tanaka Y, Tsujiuchi T: Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol Rep. 2010, 24: 501-505.
Article
CAS
PubMed
Google Scholar
Sladek NE: Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J Biochem Mol Toxicol. 2003, 17: 7-23. 10.1002/jbt.10057.
Article
CAS
PubMed
Google Scholar
Dasu A, Denekamp J: Inducible repair and intrinsic radiosensitivity: a complex but predictable relationship?. Radiat Res. 2000, 153: 279-288. 10.1667/0033-7587(2000)153[0279:IRAIRA]2.0.CO;2.
Article
CAS
PubMed
Google Scholar
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006, 444: 756-760. 10.1038/nature05236.
Article
CAS
PubMed
Google Scholar
Phillips TM, McBride WH, Pajonk F: The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006, 98: 1777-1785. 10.1093/jnci/djj495.
Article
PubMed
Google Scholar
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman , Clarke MF: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2006, 458: 780-783.
Article
Google Scholar
Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y: Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol. 2009, 34: 1381-1386.
CAS
PubMed
Google Scholar
Adhikari AS, Agarwal N, Wood BM, Porretta C, Ruiz B, Pochampally RR, Iwakuma T: CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res. 2010, 70: 4602-4612. 10.1158/0008-5472.CAN-09-3463.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang M, Zhang R, Yan M, Ye Z, Liang W, Luo Z: Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro. Biochem Biophys Res Commun. 2010, 391: 1062-1066. 10.1016/j.bbrc.2009.12.020.
Article
CAS
PubMed
Google Scholar